Position in AZN
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$38,852
New position
Shares Held
197
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Avion Wealth holds $1,746,065 across 13 Drug Manufacturers - General names. AZN ranks #7 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
727 | $668,672 | |
| 2 | JNJ |
Johnson & Johnson
|
1,586 | $387,681 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,956 | $235,287 | |
| 4 | AMGN |
Amgen Inc
|
602 | $211,813 | |
| 5 | ABBV |
AbbVie Inc.
|
397 | $86,343 | |
| 6 | PFE |
Pfizer Inc
|
1,733 | $48,662 | |
| 7 | AZN |
Astrazeneca PLC
This page
|
197 | $38,852 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
191 | $26,619 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $38,852 | 197 | Shares | Sole | 2026-05-01 | |
| No filing history on record for this holder in this stock. | ||||||